Compounds > fulvestrant
Page last updated: 2024-08-26

fulvestrant and transforming growth factor beta

fulvestrant has been researched along with transforming growth factor beta in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (16.67)18.2507
2000's10 (55.56)29.6817
2010's4 (22.22)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Bonde, SK; Gori, F; Hofbauer, LC; Rickard, DJ; Riggs, BL; Spelsberg, TC1
Jensen, EV; Knabbe, C; Müller, V1
Akinaga, S; Kurebayashi, J; Kurosumi, M; Nakata, T; Otsuki, T; Sonoo, H; Yamamoto, S1
Ikeda, K; Mizutani, K; Yamori, Y1
Anderson, JJ; Chen, X1
Klingensmith, WL; Meyn, LA; Moalli, PA; Zyczynski, HM1
Lauritsen, KJ; List, HJ; Reiter, R; Riegel, AT; Wellstein, A1
Chaturvedi, K; Sarkar, DK1
Buck, MB; Knabbe, C; Pfizenmaier, K1
Gärtner, F; Guo, S; Russo, J; Schmitt, FC; Soares, R1
Grant-Tschudy, KS; Wira, CR1
An, X; Chen, X; Du, X; Jin, H; Kang, Y; Song, X; Tai, P; Wang, B; Wang, J; Wang, S; Xia, G; Yan, J; Zhao, L1
Gust, R; Kleuser, B; Malek, D; Pertz, HH; Potteck, H1
Buck, MB; Joffroy, CM; Knabbe, C; Pfizenmaier, K; Popp, SL; Stope, MB1
Burow, ME; Croce, CM; Devlin, C; Di Leva, G; Fang, F; Hartman-Frey, C; Ivan, M; Li, M; Nephew, KP; Rao, X1
Fang, WN; Liu, HY; Liu, ZK; Peng, JP; Wang, HM; Yang, Y1
Buck, MB; Fritz, P; Joffroy, C; Knabbe, C; Popp, SL; Stope, MB1
Abdelghany, TM; Ashour, AA; Eisa, MA; Elsadek, BEM; Mansour, AM; Salama, SA1

Other Studies

18 other study(ies) available for fulvestrant and transforming growth factor beta

ArticleYear
Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen.
    The Journal of clinical investigation, 1998, Jan-15, Volume: 101, Issue:2

    Topics: Blotting, Northern; Blotting, Western; Bone Morphogenetic Protein 6; Bone Morphogenetic Proteins; Cell Line; Estradiol; Estrogens; Fulvestrant; Humans; Osteoblasts; Polymerase Chain Reaction; RNA, Messenger; Tamoxifen; Transforming Growth Factor beta

1998
Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Cancer research, 1998, Jan-15, Volume: 58, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Drug Interactions; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured

1998
A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Oncology, 1998, Volume: 55 Suppl 1

    Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; DNA Primers; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factors; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured; Up-Regulation

1998
Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
    Biochemical and biophysical research communications, 2000, Jul-21, Volume: 274, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cells, Cultured; Collagen; DNA; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fulvestrant; Glycation End Products, Advanced; Male; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Procollagen-Proline Dioxygenase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Estrogen; Resveratrol; Stilbenes; Stroke; Time Factors; Transforming Growth Factor beta

2000
Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
    Nutrition and cancer, 2001, Volume: 41, Issue:1-2

    Topics: Cell Division; Cell Survival; DNA; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression; Genistein; Glycine max; Humans; Interleukin-6; Isoflavones; Ovarian Neoplasms; Receptors, Estrogen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured

2001
Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor.
    American journal of obstetrics and gynecology, 2002, Volume: 187, Issue:1

    Topics: Adult; Cells, Cultured; Estradiol; Estrogen Antagonists; Female; Fibroblasts; Fulvestrant; Humans; Interleukin-1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Receptors, Estrogen; Transforming Growth Factor beta

2002
A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
    Oncogene, 2002, Oct-17, Volume: 21, Issue:47

    Topics: Breast Neoplasms; Cell Cycle; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Half-Life; Humans; Nuclear Receptor Coactivator 3; RNA, Messenger; Transcription Factors; Transforming Growth Factor beta; Tretinoin; Tumor Cells, Cultured

2002
Involvement of protein kinase C-dependent mitogen-activated protein kinase p44/42 signaling pathway for cross-talk between estradiol and transforming growth factor-beta3 in increasing basic fibroblast growth factor in folliculostellate cells.
    Endocrinology, 2004, Volume: 145, Issue:2

    Topics: Animals; Cell Line; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Estradiol; Female; Fibroblast Growth Factor 2; Fulvestrant; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Pituitary Gland, Anterior; Protein Kinase C; Rats; Rats, Inbred F344; Receptors, Estrogen; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta3

2004
Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
    Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:7

    Topics: Breast Neoplasms; Cell Proliferation; Cyclin A; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Humans; Mutation; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Smad2 Protein; Smad3 Protein; Smad4 Protein; Tamoxifen; Trans-Activators; Transforming Growth Factor beta; Tumor Cells, Cultured

2004
17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk.
    Angiogenesis, 2003, Volume: 6, Issue:4

    Topics: Adrenal Medulla; Animals; Aorta; Blotting, Western; Breast Neoplasms; Cattle; Cell Line; Cell Line, Tumor; Coculture Techniques; Collagen; Culture Media, Conditioned; Culture Media, Serum-Free; Drug Combinations; Endothelium, Vascular; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Humans; Laminin; Muscle, Smooth; Neovascularization, Pathologic; Proteoglycans; Receptor Cross-Talk; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Umbilical Veins

2003
Effect of oestradiol on mouse uterine epithelial cell tumour necrosis factor-alpha release is mediated through uterine stromal cells.
    Immunology, 2005, Volume: 115, Issue:1

    Topics: Animals; Cell Culture Techniques; Coculture Techniques; Culture Media, Conditioned; Epithelial Cells; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Mice; Mice, Inbred BALB C; Stromal Cells; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Uterus

2005
Induction of regulatory T cells by physiological level estrogen.
    Journal of cellular physiology, 2008, Volume: 214, Issue:2

    Topics: Animals; Animals, Outbred Strains; Biomarkers; CD4 Antigens; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Forkhead Transcription Factors; Fulvestrant; Immune Tolerance; Immunomagnetic Separation; Injections, Subcutaneous; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred C57BL; Ovariectomy; Pregnancy; Spleen; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Uterus

2008
17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
    Molecular pharmacology, 2008, Volume: 74, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Silencing; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Transforming Growth Factor beta

2008
Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
    Cancer research, 2010, Feb-15, Volume: 70, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor Modulators; Female; Forkhead Transcription Factors; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immune Tolerance; Tamoxifen; Transforming Growth Factor beta

2010
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
    Oncogene, 2011, Mar-03, Volume: 30, Issue:9

    Topics: Antineoplastic Agents; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; Selective Estrogen Receptor Modulators; Signal Transduction; Transforming Growth Factor beta; Up-Regulation

2011
Insulin-like growth factor binding protein 7 modulates estrogen-induced trophoblast proliferation and invasion in HTR-8 and JEG-3 cells.
    Cell biochemistry and biophysics, 2012, Volume: 63, Issue:1

    Topics: Antibodies, Neutralizing; Cell Line; Cell Movement; Cell Proliferation; Estradiol; Estrogens; Extracellular Signal-Regulated MAP Kinases; Fulvestrant; Humans; Insulin-Like Growth Factor Binding Proteins; Interferon-gamma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Phosphorylation; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Recombinant Proteins; Transforming Growth Factor beta; Trophoblasts

2012
Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box Binding Protein-1.
    Anticancer research, 2013, Volume: 33, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Signal Transduction; Survival Rate; Tamoxifen; Transforming Growth Factor beta; Y-Box-Binding Protein 1

2013
Estrogen/estrogen receptor activation protects against DEN-induced liver fibrosis in female rats via modulating TLR-4/NF-kβ signaling.
    European journal of pharmacology, 2023, Dec-05, Volume: 960

    Topics: Animals; Biomarkers; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; Humans; Liver Cirrhosis; Male; Nitrosamines; Ovariectomy; Rats; Signal Transduction; Silymarin; Toll-Like Receptor 4; Transforming Growth Factor beta

2023